← Leaderboards
Benjamin Peter Kleinstiver
Massachusetts General Hospital
$4,326,064
Attributed
$4,921,390
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,921,390 · 5
By mechanism
DP2$2,502,000 · 1
R01$1,190,652 · 1
R00$729,889 · 1
P01$355,479 · 1
K99$143,370 · 1
Top collaborators
- Shaf Keshavjee2 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Shengdar Tsai$7,312,012
- Joren C Madsen$70,026,219
- Marcela Valderrama Maus$16,508,365
- J. Keith Joung$24,183,955
- Ralph Mazitschek$5,975,673
Others in their field
Other Emerging Leaders on “Technology”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$436,612,396
- Valerie Koch · University Corporation For Atmospheric Res$252,793,840
- Joel A Lipkin · Four Points Technology, Llc$178,737,225
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
Research focus
TechnologyCrispr/Cas TechnologyEngineeringClustered Regularly Interspaced Short Palindromic RepeatsGenome EditingSiteGene TherapyGenomeInnovationIn VivoGenesSafetyPropertyDesignResearch PersonnelMalignant NeoplasmsSpecificityMassachusettsPositioning AttributeGeneral HospitalsFutureClinicMediatingKnockout Gene
Grant awards (9)
Scalable Development of Custom Genome Editing Technologies$990,000
DP2 · FY2025 · CA · contact PI
Immunoengineering of donor lungs to optimize long-term graft function$584,781
R01 · FY2025 · AI
CORE 2: Genetic Engineering Core$355,479
P01 · FY2025 · HL · contact PI
Immunoengineering of donor lungs to optimize long-term graft function$605,871
R01 · FY2024 · AI
Scalable Development of Custom Genome Editing Technologies$1,512,000
DP2 · FY2022 · CA · contact PI
Optimizing Cancer Immunotherapy Safety and Efficacy using Genome Editing$248,999
R00 · FY2020 · CA · contact PI
Optimizing Cancer Immunotherapy Safety and Efficacy using Genome Editing$231,891
R00 · FY2019 · CA · contact PI
Optimizing Cancer Immunotherapy Safety and Efficacy using Genome Editing$248,999
R00 · FY2018 · CA · contact PI
Optimizing Cancer Immunotherapy Safety and Efficacy using Genome Editing$143,370
K99 · FY2017 · CA · contact PI